1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Izotropic Corporation

Izotropic Corporation

IZO.CN
Izotropic CorporationCA flagCanadian Securities Exchange
0.27
CAD
+0.01
- -
18.28MMarket Cap
Izotropic Corporation
IZO.CN
(Canadian Securities Exchange)

Recent

price

0.27

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.03
-0.02
-0.05
-0.14
-0.15
-0.11
-0.03
-0.05
-0.05
Basic EPS, GAAP
- -
-0.03
-0.02
-0.04
-0.09
-0.11
-0.07
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.02
0.01
0.02
0.08
-0.06
-0.09
-0.09
-0.12
-0.12
Book Value per Share
- -
0.02
0.01
0.03
0.13
-0.01
-0.06
-0.07
-0.08
-0.08
Tangible Book Value per Share
22
22
23
25
35
43
50
54
59
57
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
- -
-1
-5
-7
-6
-2
-3
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
1
5
- -
-3
-4
-5
-5
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
1
5
- -
-3
-4
-5
-5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-130.91
-370.47
-321.39
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'25
Jan'25
Apr'25
ST Debt
2
2
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
57
61
64
Market Capitalization
3
13
14

Working Capital

FRC

•

in mil. unless spec.
Oct'25
Jan'25
Apr'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
5
5
Payables & Accruals
3
3
3
ST Debt
2
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
240.5%
26.33%
Free Cash Flow
- -
32.35%
7.38%
Net Income, GAAP
- -
75.6%
101.09%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.03
2025
-0.02
-0.01
-0.01
- -
-0.05
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
DarioHealth Corp. (DRIO)
WuXi AppTec Co., Ltd. (WUXAY)
Prenetics Global Limited (PRE)
DermTech, Inc. (DMTK)
Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)
Health S.A. (MLAHC.PA)
Business
Izotropic Corporation is a MedTech enterprise specializing in advanced diagnostic imaging for the early detection and characterization of breast cancers. The company is actively commercializing its flagship product, the IzoView Breast CT Imaging System, a dedicated 3D platform that delivers high-resolution volumetric imaging without breast compression. This innovative system integrates artificial intelligence for image reconstruction and offers a patent-pending personalized radiation dose, particularly addressing the challenges in detecting cancer in women with dense breast tissue. The corporation was formed in 2016 and is headquartered in Surrey, Canada.